Red Flags Detected
- Going Concern (worsened) — Auditor added explicit going-concern paragraph; management states $18M Future Pak payment insufficient to alleviate substantial doubt through March 2027 (extended from March 2026 baseline).
- Asset Impairment (new) — Recorded $800K impairment on in-process R&D intangible asset triggered by market capitalization decline, first write-down since business combination.
- Delisting (new) — Nasdaq issued deficiency notice March 2026 for sub-$1 bid price; company ineligible for standard compliance period due to prior reverse splits, appealed but outcome uncertain.
Jaguar licenses Mytesi to Future Pak for $18M, shifts to rare-disease R&D amid going-concern warning
Filed April 7, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 31, 2025 · ~2 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade JAGX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 3, 2026 6:52 PM